NCT07540637Recruiting
Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
Assessment of Treatment Adherence and Associated Factors in Chronic Hepatitis B Patients With Supported Management by the HBVCare Application.
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
Adherence to chronic Hepatitis B (HBV) treatment and regular follow-up visits is essential for preventing dangerous complications, yet adherence rates in Vietnam remain low due to barriers in patient awareness and geographic conditions. Digital health solutions, particularly mobile applications, have shown potential as tools for supporting patients in proactive disease management. The HBVCare mobile application was developed to provide features such as medication reminders, storage of lab results, and health education to improve treatment adherence and clinical outcomes. The investigators are conducting a multicenter, randomized controlled trial at Hoang Long Clinic and Hanoi Medical University Hospital to evaluate the effectiveness of HBVCare. Patients are randomized into either a control group receiving standard care and an intervention group using the HBVCare app, with patient adherence and related factors assessed after three months of treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 4 Apr 2026
- Start date
- Apr 2026
- Primary completion date
- Nov 2026
- Lead sponsor
- Institute of Gastroenterology and Hepatology, Vietnam
- Diseases
- Hepatitis B
- NCT number
- NCT07540637
What you commit to
- Study type: Interventional
- Planned participants: 70
- From Apr 2026 to the primary completion date, Nov 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental health disorders, cognitive impairment, or difficulties in communication and mobile application usage.
- Severe comorbid chronic conditions, such as heart failure, kidney failure, or respiratory failure.
- Presence of severe complications, including gastrointestinal bleeding, liver cancer, hepatic encephalopathy, or acute liver failure.
Who the study is looking for
- Age ≥ 18 years.
- Diagnosis of Chronic Hepatitis B (CHB): HBsAg (+) and/or HBV DNA positive for ≥ 6 months; Or HBsAg positive and anti-HBc IgM negative.
- Smartphone ownership (iOS or Android) with an active internet connection and the ability to install the HBVCare application.
- Sufficient literacy to read and understand Vietnamese and respond to study questions.
- Provision of informed consent to participate in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute of Gastroenterology and Hepatology Coordinator of this site? Confirm its status | Hanoi | Vietnam | Recruiting |
| Hanoi Medical University Hospital Coordinator of this site? Confirm its status | Hanoi | Vietnam | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.